<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>http://finance.google.com/group/google.finance.713863</id>
  <title type="text">3SBio Inc. Google Group</title>
  <subtitle type="text">
  Google Finance Discussion for 3SBio Inc.
  </subtitle>
  <link href="/group/google.finance.713863/feed/atom_v1_0_msgs.xml" rel="self" title="3SBio Inc. feed"/>
  <updated>2009-11-19T12:33:36Z</updated>
  <generator uri="http://finance.google.com" version="1.99">Google Groups</generator>
  <entry>
  <author>
  <name>tanu</name>
  <email>tanumoydutta1...@gmail.com</email>
  </author>
  <updated>2009-11-19T12:33:36Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/b56dba6f458750b3/fd416f3584dbc351?show_docid=fd416f3584dbc351</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/b56dba6f458750b3/fd416f3584dbc351?show_docid=fd416f3584dbc351"/>
  <title type="text">Positive Phase 3 results of an erectile dysfunction (ED) drug</title>
  <summary type="html" xml:space="preserve">
  VIVUS Inc. (VVUS) reported positive results for Avanafil, their &lt;br&gt; erectile dysfunction (ED) drug. New BioMedicine had issued a report &lt;br&gt; with positive coverage of this event on May 5, 2009. Stock up 111.7% &lt;br&gt; from the date of our coverage till after the news announcement. To &lt;br&gt; know about the disease, the drug, the market potential, the
  </summary>
  </entry>
  <entry>
  <author>
  <name>babu</name>
  <email>sudipbanerjeeos...@gmail.com</email>
  </author>
  <updated>2009-11-12T12:24:41Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/93f5b9f7a2488e57/c0e23a106afb1abb?show_docid=c0e23a106afb1abb</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/93f5b9f7a2488e57/c0e23a106afb1abb?show_docid=c0e23a106afb1abb"/>
  <title type="text">Positive data from an early stage trial of a sarcoma drug.........</title>
  <summary type="html" xml:space="preserve">
  Threshold Pharmaceuticals, Inc. (THLD) reported positive results for &lt;br&gt; TH-302, their sarcoma drug. New BioMedicine issued positive coverage &lt;br&gt; of this event on August 18, 2009. The stock is up 115% from the date &lt;br&gt; of our coverage. To read our report, which covers the disease, the &lt;br&gt; drug, the market potential, the competition, etc., access it FREE at:
  </summary>
  </entry>
  <entry>
  <author>
  <name>debapriyadutta</name>
  <email>debapriya2...@yahoo.com</email>
  </author>
  <updated>2009-06-29T12:29:09Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/f896317870a91bf5/68af2de2a5e604e0?show_docid=68af2de2a5e604e0</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/f896317870a91bf5/68af2de2a5e604e0?show_docid=68af2de2a5e604e0"/>
  <title type="text">FDA Decision on approval of a small cap company&#39;s drug for Anemia on June 29th</title>
  <summary type="html" xml:space="preserve">
  The upcoming FDA Decision date on JUNE 29th (TODAY) for this small cap &lt;br&gt; company&#39;s drug for Anemia patients will affect SSRX directly. To read &lt;br&gt; about HOW it will affect SSRX and about our opinion on whether the &lt;br&gt; drug will be approved or not, along with details of the company, the &lt;br&gt; drug, the disease, the competitors, the market and the sales potential
  </summary>
  </entry>
  <entry>
  <author>
  <name>ritushreeya</name>
  <email>ritushre...@gmail.com</email>
  </author>
  <updated>2009-06-27T09:48:28Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/9108694f58153531/df25f74f73fe835e?show_docid=df25f74f73fe835e</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/9108694f58153531/df25f74f73fe835e?show_docid=df25f74f73fe835e"/>
  <title type="text">Upcoming FDA Approval of a small cap company&#39;s drug for Anemia patients</title>
  <summary type="html" xml:space="preserve">
  The upcoming FDA Decision date on JUNE 29th (Monday) for this small &lt;br&gt; cap company&#39;s drug for Anemia patients will affect SSRX directly. To &lt;br&gt; read about HOW it will affect SSRX and about our opinion on whether &lt;br&gt; the drug will be approved or not, along with details of the company, &lt;br&gt; the drug, the disease, the competitors, the market and the sales
  </summary>
  </entry>
  <entry>
  <author>
  <name>kamalika4321</name>
  <email>kamalika4...@yahoo.com</email>
  </author>
  <updated>2009-06-26T11:52:27Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/ac2bd25ce55bd3cb/438a8a1d19070193?show_docid=438a8a1d19070193</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/ac2bd25ce55bd3cb/438a8a1d19070193?show_docid=438a8a1d19070193"/>
  <title type="text">Upcoming FDA Decision on June 29th on approval of a small cap company&#39;s drug for Anemia patients</title>
  <summary type="html" xml:space="preserve">
  The upcoming FDA Decision date on JUNE 29th (Monday) for this small &lt;br&gt; cap company&#39;s drug for Anemia patients will affect SSRX directly. To &lt;br&gt; read about HOW it will affect SSRX and about our opinion on whether &lt;br&gt; the drug will be approved or not, along with details of the company, &lt;br&gt; the drug, the disease, the competitors, the market and the sales
  </summary>
  </entry>
  <entry>
  <author>
  <name>Debarati</name>
  <email>biswas_debar...@yahoo.com</email>
  </author>
  <updated>2009-06-25T11:22:15Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/8a18212c20fe41de/60ead53b741088bf?show_docid=60ead53b741088bf</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/8a18212c20fe41de/60ead53b741088bf?show_docid=60ead53b741088bf"/>
  <title type="text">Upcoming Clinical Trials data of a small cap company&#39;s Alzheimer&#39;s drug to be presented in July</title>
  <summary type="html" xml:space="preserve">
  A small cap company is going to be presenting data on their &lt;br&gt; Alzheimer&#39;s drug at the Alzheimer&#39;s conference in July. If the trials &lt;br&gt; data is positive, it brings the company one step closer to the &lt;br&gt; approval of a breakthrough treatment for Alzheimer&#39;s disease. To find &lt;br&gt; out about the company, the drug, how the drug works, who are the other
  </summary>
  </entry>
  <entry>
  <author>
  <name>lopamudra</name>
  <email>lopa86...@gmail.com</email>
  </author>
  <updated>2009-06-24T13:06:18Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/608300cd878ec2c3/8e96c50e569f8a31?show_docid=8e96c50e569f8a31</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/608300cd878ec2c3/8e96c50e569f8a31?show_docid=8e96c50e569f8a31"/>
  <title type="text">Upcoming FDA Panel recommendation on June 26th of a small cap company&#39;s Opthalmic (eye) drug.</title>
  <summary type="html" xml:space="preserve">
  FDA Panel meeting on Friday (June 26th) to recommend approval on a &lt;br&gt; small cap company&#39;s opthalmic drug. If the drug is eventually &lt;br&gt; approved, the Peak Sales of this drug could reach over 100% of the &lt;br&gt; current market cap of the company. To read about the drug, the &lt;br&gt; disease, the market, and how the drug compares to competitors, get a
  </summary>
  </entry>
  <entry>
  <author>
  <name>lopamudra</name>
  <email>lopa86...@gmail.com</email>
  </author>
  <updated>2009-06-22T13:20:34Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/c6f3194b27edce8c/49dafcdf827ce19e?show_docid=49dafcdf827ce19e</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/c6f3194b27edce8c/49dafcdf827ce19e?show_docid=49dafcdf827ce19e"/>
  <title type="text">Upcoming FDA decision on the approval of a small cap company&#39;s Depression drug</title>
  <summary type="html" xml:space="preserve">
  The FDA approval decision date for a small cap company&#39;s Depression &lt;br&gt; drug is coming up in July. If approved, this could become a &lt;br&gt; breakthrough treatment for Depression and take a sizable bite out of &lt;br&gt; major players like Forest Labs and Wyeth&#39;s market share. To find out &lt;br&gt; what the chances are of this new drug being approved, how the drug
  </summary>
  </entry>
  <entry>
  <author>
  <email>erede...@gmail.com</email>
  </author>
  <updated>2008-09-23T18:27:34Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/5403ed8e0f8d7353/297244f10df6b289?show_docid=297244f10df6b289</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/5403ed8e0f8d7353/297244f10df6b289?show_docid=297244f10df6b289"/>
  <title type="text">High Volume and down... why?</title>
  <summary type="html" xml:space="preserve">
  What is happening with this stock? Seems like it should be on the up &lt;br&gt; and up, but its being very volatile. Any explanations?
  </summary>
  </entry>
  <entry>
  <author>
  <email>geowo...@gmail.com</email>
  </author>
  <updated>2008-06-06T18:39:44Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/ace3b2a5fdba6671/f1a133eb6ee23f9b?show_docid=f1a133eb6ee23f9b</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/ace3b2a5fdba6671/f1a133eb6ee23f9b?show_docid=f1a133eb6ee23f9b"/>
  <title type="text">Long term strategy</title>
  <summary type="html" xml:space="preserve">
  3SBio is selling Amgen and Biogen&#39;s drugs to the world&#39;s biggest, but &lt;br&gt; not the world&#39;s richest market...at least not yet. That makes for very &lt;br&gt; strong promise for the very long term IMHO. &lt;br&gt; &lt;p&gt;China Investment Guidance #1 Newsletter, China Stock Digest &lt;br&gt; &lt;p&gt;New investing guidebook, “Becoming Your Own China Stock Guru” is
  </summary>
  </entry>
  <entry>
  <author>
  <email>jmilh...@gmail.com</email>
  </author>
  <updated>2008-03-20T14:00:49Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/82c7d04641cf40c5/413236984204f2c5?show_docid=413236984204f2c5</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/82c7d04641cf40c5/413236984204f2c5?show_docid=413236984204f2c5"/>
  <title type="text">Re: Stock buyback = Short-squeeze = Payday for longs</title>
  <summary type="html" xml:space="preserve">
  Yep, and kudos to 3sbio for buying back at a great price. &lt;br&gt; Market cap on this deserves at least $300M, so I can&#39;t imagine who &lt;br&gt; would be short on this stock with PPS in the mid $7&#39;s, but you are &lt;br&gt; right that there could be a short squeeze going on.
  </summary>
  </entry>
  <entry>
  <author>
  <email>jcarc...@gmail.com</email>
  </author>
  <updated>2008-03-19T23:42:56Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/82c7d04641cf40c5/a2abc683ddc61caa?show_docid=a2abc683ddc61caa</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/82c7d04641cf40c5/a2abc683ddc61caa?show_docid=a2abc683ddc61caa"/>
  <title type="text">Stock buyback = Short-squeeze = Payday for longs</title>
  <summary type="html" xml:space="preserve">
  Amen, a stock buy-back, enjoy the short squeeze. --Longs finally get &lt;br&gt; paid. &lt;br&gt; &lt;p&gt;position: overweight,strong buy, long
  </summary>
  </entry>
  <entry>
  <author>
  <email>prashantpri...@yahoo.com</email>
  </author>
  <updated>2008-01-24T01:43:10Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/6962cfed6e46b30b/e886b5252a078d10?show_docid=e886b5252a078d10</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/6962cfed6e46b30b/e886b5252a078d10?show_docid=e886b5252a078d10"/>
  <title type="text">whats deal with ssrx ?</title>
  <summary type="html" xml:space="preserve">
  I bought ssrx considering his fundament and pipeline. &lt;br&gt; &lt;p&gt;I dont know company is not bringing any news!!! &lt;br&gt; &lt;p&gt;Where is CEO ? what he does ?
  </summary>
  </entry>
  <entry>
  <author>
  <email>w...@hotmail.com</email>
  </author>
  <updated>2007-11-27T20:48:58Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/ccd27bca55c713aa/69385bde10646ccf?show_docid=69385bde10646ccf</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/ccd27bca55c713aa/69385bde10646ccf?show_docid=69385bde10646ccf"/>
  <title type="text">SSRX is still worth investing.</title>
  <summary type="html" xml:space="preserve">
  even though SSRX dropped again today, i still believe the fundementals &lt;br&gt; of the firm are good with competitive products and high demands. Do &lt;br&gt; not panic. It is better to hold stocks for a while. Do not let &lt;br&gt; speculators have chance to scare us away in order to take in cheaper &lt;br&gt; stocks and pull them back in future. Something strange here dont make
  </summary>
  </entry>
  <entry>
  <author>
  <email>eed2sellingst...@gmail.com</email>
  </author>
  <updated>2007-11-24T22:05:36Z</updated>
  <id>http://finance.google.com/group/google.finance.713863/browse_thread/thread/ccd27bca55c713aa/5bc5bb911f233fcc?show_docid=5bc5bb911f233fcc</id>
  <link href="http://finance.google.com/group/google.finance.713863/browse_thread/thread/ccd27bca55c713aa/5bc5bb911f233fcc?show_docid=5bc5bb911f233fcc"/>
  <title type="text">Re: Why SSRX dropping at such a high percentage for a stock under $20</title>
  <summary type="html" xml:space="preserve">
  i agree with you on that! &lt;br&gt; &lt;p&gt;i bought at 13.80 before the reports.... &lt;br&gt; sold the next day at 16.40 and then it came down &lt;br&gt; &lt;p&gt;bought in again at 13.60 &lt;br&gt; &lt;p&gt;now i will hold again ^^
  </summary>
  </entry>
</feed>
